Post Profile






New impetus for treatment neurodegenerative diseases

(University of Groningen) Twenty years ago, tumor necrosis factor (TNF) seemed a promising target in the treatment of brain diseases like multiple sclerosis or Alzheimer's Disease. But clinical trials produced disappointing results. Now University of Groningen scientists and a group of European colleagues have made an important discovery that explains the failure of these trials, and points the way to promising new treatments.
read more

share

Related Posts


New Target Identified in Fight Against Alzheimer's, Multiple Sclerosis

Health : Newswise Medical News

Highlighting a potential target in the treatment of multiple sclerosis (MS) and Alzheimer's disease, new research suggests that triggering a protein found on the surface of brain cells may help slow the progression of these and othe...

Alzheimer's disease could be treated with gene therapy, suggests animal study

Health : EurekAlert: Health

(Imperial College London) Researchers have prevented the development of Alzheimer's disease in mice by using a virus to deliver a specific gene into the brain. The early-stage findings, by scientists from Imperial College London, op...

Alzheimer’s disease and memory problems risk may be lowered by eating baked and broiled fish

Health : Bel Marra Health

Alzheimer’s disease and memory problem risks may be lowered by eating baked and broiled fish. Study author Nikolaos Scarmeas said, “While it’s not easy to measure the level of beta-amyloid deposits in the brain in this type of study...

How tumor necrosis factor protects against infection

Academics / General Science : ScienceDaily: Science Society

Tumor necrosis factor (TNF), a messenger substance in the immune system, plays an important role in triggering chronic inflammatory diseases. For this reason, TNF inhibitors are a standard form of treatment for patients with rheumat...

New Drug For Alzheimer's, Parkinson's, Brain Injury, Shows Promise

Health : Medical News Today

A "one-size-fits-all" new class of drugs that targets a particular type of brain inflammation is showing early promise for the treatment of Alzheimer's disease, Parkinson's disease, multiple sclerosis and traumatic brain injury. A p...

Comments


Copyright © 2016 Regator, LLC